| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 57.881 | 59.476 | 62.441 | 67.500 | 79.003 | 104.968 | 109.817 | 109.453 | 127.716 | 159.348 |
| Total Income - EUR | 57.926 | 60.122 | 62.667 | 67.501 | 80.369 | 104.969 | 109.818 | 109.455 | 127.733 | 159.466 |
| Total Expenses - EUR | 34.066 | 36.430 | 47.772 | 50.021 | 53.827 | 59.338 | 92.742 | 68.141 | 60.684 | 79.366 |
| Gross Profit/Loss - EUR | 23.860 | 23.692 | 14.895 | 17.480 | 26.541 | 45.631 | 17.076 | 41.314 | 67.049 | 80.100 |
| Net Profit/Loss - EUR | 22.122 | 22.863 | 13.905 | 16.805 | 25.741 | 44.638 | 15.978 | 40.219 | 65.774 | 75.392 |
| Employees | 2 | 3 | 4 | 5 | 5 | 5 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - Sor-Ines Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.014 | 990 | 68.486 | 79.463 | 105.415 | 98.988 | 69.087 | 64.861 | 60.227 | 104.726 |
| Current Assets | 54.521 | 38.539 | 9.847 | 11.260 | 11.936 | 36.800 | 31.781 | 16.612 | 54.056 | 33.036 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.289 | 8.324 | 7.421 | 6.703 | 8.983 | 11.340 | 5.890 | 9.386 | 10.105 | 7.070 |
| Cash | 53.232 | 30.215 | 2.425 | 4.557 | 2.952 | 25.461 | 25.891 | 7.226 | 43.951 | 25.966 |
| Shareholders Funds | 56.948 | 34.981 | 25.818 | 42.150 | 62.438 | 100.454 | 69.731 | 77.722 | 110.633 | 108.948 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.587 | 4.548 | 52.514 | 48.573 | 54.912 | 35.335 | 31.137 | 3.751 | 3.650 | 28.815 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sor-Ines Med Srl